Substituted pyrido[3,4-b]pyrazines as Syk inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9434726
APP PUB NO 20140121200A1
SERIAL NO

14124325

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided are pyridopyrazine compounds of formula (I), pharmaceutical compositions thereof and methods of use therefore, wherein R1, R2, R3, R4 and m are as defined in the specification.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HUTCHISON MEDIPHARMA LIMITED201203 SHANGHAI ZHANGJIANG HI TECH PARK CAI LUN ROAD NO 4 LANE 720 MUNICIPAL DISTRICT SHANGHAI CITY 201203

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Deng, Wei Shanghai, CN 180 1768
Ji, Jianguo Shanghai, CN 69 1055
Su, Wei-Guo Shanghai, CN 60 343

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 6, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00